Browse by Aston Author

Article

Lisetto, Manuel, Fattorini, Mariagiulia, Lanza, Andrea, Gerdol, Marco, Griffin, Martin, Wang, Zhuo, Ferrara, Fortunato and Sblattero, Daniele (2023). Biochemical and Functional Characterization of the Three Zebrafish Transglutaminases 2. International Journal of Molecular Sciences, 24 (15),

Pinton, Giulia, Wang, Zhuo, Balzano, Cecilia, Missaglia, Sara, Tavian, Daniela, Boldorini, Renzo, Fennell, Dean A., Griffin, Martin and Moro, Laura (2022). Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition. Frontiers in Oncology, 12 ,

Pinton, Giulia, Wang, Zhuo, Balzano, Cecilia, Missaglia, Sara, Tavian, Daniela, Boldorini, Renzo, Fennell, Dean A., Griffin, Martin and Moro, Laura (2021). CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition. Frontiers in Oncology, 11 ,

Fell, Shaun, Wang, Zhuo, Blanchard, Andy, Nanthakumar, Carmel and Griffin, Martin (2021). Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors. Amino Acids, 53 (2), pp. 205-217.

Ayinde, Oluseyi, Wang, Zhuo, Pinton, Giulia, Moro, Laura and Griffin, Martin (2019). Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition. Oncotarget, 10 (44), pp. 4556-4569.

Wang, Zhuo, Stuckey, Daniel J., Murdoch, Colin E., Camelliti, Patrizia, Lip, Gregory Y.H. and Griffin, Martin (2018). Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. Cell Death and Disease, 9 ,

Wang, Zhuo, Perez, Mileidys, Lee, Eun-Seo, Kojima, Soichi and Griffin, Martin (2017). The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition. Cell Death and Disease, 8 (9),

Feriotto, G., Calza, R., Bergamini, C.M., Griffin, M., Wang, Z., Beninati, S., Ferretti, V., Marzola, E., Guerrini, R., Pagnoni, A., Cavazzini, A., Casciano, F. and Mischiati, C. (2017). Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten. Amino Acids, 49 (3), 551–565.

Ayinde, Oluseyi, Wang, Zhuo and Griffin, Martin (2017). Tissue transglutaminase induces epithelial-mesenchymal-transition and the acquisition of stem cell like characteristics in colorectal cancer cells. Oncotarget, 8 (12), pp. 20025-20041.

Zonca, Sara, Pinton, Giulia, Wang, Zhuo, Soluri, Maria Felicia, Tavian, Daniela, Griffin, Martin, Sblattero, Daniele and Moro, Laura (2017). Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia. Cell Death and Disease, 8 (2),

Nyabam, Samuel, Wang, Zhuo, Thibault, Thomas, Ayinde, Oluseyi, Basar, Rameeza, Marshall, Lindsay and Griffin, Martin (2016). A novel regulatory role for tissue transglutaminase in epithelial-mesenchymal transition in cystic fibrosis. BBA - Molecular Cell Research, 1863 (9), pp. 2234-2244.

Badarau, Eduard, Wang, Zhuo, Rathbone, Dan L., Costanzi, Andrea, Thibault, Thomas, Murdoch, Colin E., El Alaoui, Said, Bartkeviciute, Milda and Griffin, Martin (2015). Development of potent and selective tissue transglutaminase inhibitors:their effect on TG2 function and application in pathological conditions. Chemistry and Biology, 22 (10), pp. 1347-1361.

Nadella, Vinod, Wang, Zhuo, Johnson, Timothy S., Griffin, Martin and Devitt, Andrew (2015). Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells. BBA - Molecular Cell Research, 1853 (1), pp. 201-212.

Nadalutti, Cristina A., Korponay-Szabo, Ilma R., Kaukinen, Katri, Wang, Zhuo, Griffin, Martin, Mäki, Markku and Lindfors, Katri (2013). Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA. PLoS ONE, 8 (10),

Wang, Zhuo and Griffin, Martin (2013). The role of TG2 in regulating S100A4-mediated mammary tumour cell migration. PLoS ONE, 8 (3),

Wang, Z., Perez, M., Caja, S., Melino, G., Johnson, T.S., Lindfors, K. and Griffin, M. (2013). A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis. Cell Death and Disease, 4 (9),

Wang, Zhuo, Collighan, Russell, Pytel, Kamila, Rathbone, Dan L, Li, Xiaoling and Griffin, Martin (2012). Characterization of heparin-binding site of tissue transglutaminase:its importance in cell surface targeting, matrix deposition, and cell signaling. Journal of Biological Chemistry, 287 (16), pp. 13063-13083.

Kotsakis, Panayiotis, Wang, Zhuo, Collighan, Russell John and Griffin, Martin (2011). The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26. Amino Acids, 41 (4), pp. 909-921.

Wang, Zhuo, Collighan, Russell J, Gross, Stephane R, Danen, Erik H. J., Orend, Gertraud, Telci, Dilek and Griffin, Martin (2010). RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 and α5β1 integrin co-signaling. Journal of Biological Chemistry, 285 (51), pp. 40212-40129.

Telci, Dilek, Wang, Zhuo, Li, Xiaoling, Verderio, Elisabetta A.M., Humphries, Martin J., Baccarini, Manuela, Basaga, Huveyda and Griffin, Martin (2008). Fibronectin-tissue transglutaminase matrix rescues RGD-impaired celladhesion through syndecan-4 and β integrin co-signaling. Journal of Biological Chemistry, 283 (30), pp. 20937-20947.

Thesis

Wang, Zhuo (2010). The importance of the tissue transglutaminase-fibronectin heterocomplex in the RGD-independent cell adhesion and fibronectin matrix deposition. PHD thesis, Aston University.